LRMR
Larimar Therapeutics Inc
3.80$
-3.3%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +175.0% | +9.1% | – | – | +202.9% | -11.3% | +38.8% | -70.1% | +98.7% | +110.3% | -16.6% | +14.3% | +2.3% | +10.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.2% | -17.2% | +186.5% | +99.4% | -27.2% | +4.9% | +18.7% | -58.0% | +51.1% | +22.3% | -36.8% | +14.1% | +164.8% | +110.5% | |
| – | – | – | – | +135.8% | -4.7% | -33.5% | -87.5% | +59.8% | +370.2% | +5.9% | +1.7% | +14.8% | +25.0% | +3.8% | |
| – | +4.8% | -0.1% | +158.1% | +107.5% | -22.8% | -5.7% | +16.3% | -62.8% | +84.4% | +17.9% | -27.6% | +14.3% | +117.7% | +89.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -7.4% | -56.9% | +179.8% | -74.7% | +617.9% | -100.0% | – | -2.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.